CRNX (Crinetics Pharmaceuticals) Inventories, Work In Process: $3.04 Mil (As of Mar. 2026)


CRNX Crinetics Pharmaceuticals Inc CRNX
47 GF Score
Price $42.23
GF Value $703.28
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Crinetics Pharmaceuticals Inventories, Work In Process?

Crinetics Pharmaceuticals CRNX +9.23% 47 Inventories, Work In Process is $3.04 Mil as of Mar. 2026. GuruFocus rates CRNX with a GF Score™ of 47/100 and a GF Value™ of $703.28 (Possible Value Trap). The stock has 5 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Crinetics Pharmaceuticals's work in process for the quarter that ended in Mar. 2026 was $3.04 Mil.

Crinetics Pharmaceuticals Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Crinetics Pharmaceuticals's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Crinetics Pharmaceuticals Inventories, Work In Process Chart

Crinetics Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Crinetics Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 3.04
CRNX
47GF Score
Crinetics Pharmaceuticals Inc CRNX
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Crinetics Pharmaceuticals Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of $3.04 Mil mean?
Crinetics Pharmaceuticals (CRNX) has a Inventories, Work In Process of $3.04 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Crinetics Pharmaceuticals and its competitors.
Is Crinetics Pharmaceuticals' Inventories, Work In Process too high?
Crinetics Pharmaceuticals' current Inventories, Work In Process is $3.04 Mil. Overall, Crinetics Pharmaceuticals has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Crinetics Pharmaceuticals' Inventories, Work In Process compare to CPRX and NAMS?
Crinetics Pharmaceuticals' Inventories, Work In Process of $3.04 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Biotechnology company?
A good Inventories, Work In Process depends on the Biotechnology industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Crinetics Pharmaceuticals and its competitors. Crinetics Pharmaceuticals's current Inventories, Work In Process is $3.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crinetics Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Crinetics Pharmaceuticals (CRNX) is currently considered Possible Value Trap. The stock's GF Value™ is $703.28, compared to a current price of $42.23 — trading 94% below its estimated fair value. The current Inventories, Work In Process is $3.04 Mil. Crinetics Pharmaceuticals' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Crinetics Pharmaceuticals (CRNX), the current Inventories, Work In Process is $3.04 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Crinetics Pharmaceuticals (CRNX) Overvalued in 2026?

Based on GuruFocus' analysis, Crinetics Pharmaceuticals stock appears to be undervalued. The current stock price of $42.23 is trading 94% below its estimated GF Value™ of $703.28. GuruFocus considers Crinetics Pharmaceuticals to be Possible Value Trap.

Key valuation signals for CRNX:

  • Inventories, Work In Process: $3.04 Mil
  • GF Value™: $703.28 vs. price of $42.23 (94% below fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the CRNX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Crinetics Pharmaceuticals Business Description

Other Exchanges 6Z4:Germany
Address 6055 Lusk Boulevard, San Diego, CA, USA, 92121
Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.
47GF Score

Get the complete analysis for CRNX

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$42.23
Price
$703.28
GF Value